Joanne Van Zuidam
Editor

Joanne Van Zuidam is the editor of Drug Discovery & Development. An experienced health editor, she previously served as editor of Optometric Office magazine, a publication highlighting new products and technology for eye care professionals. As a freelance writer, she has written extensively on a broad range of health and wellness topics for numerous national magazines and websites. 

The European Society for Medical Oncology (ESMO) is wrapping up. About 24,000 people from 131 countries attended the congress this year. With a record number...
9.12.2017
12:33pm
New research from Queens University Belfast has revealed that aspirin could reverse the effects of tooth decay.
9.11.2017
11:38am
A new study from Boston’s Children’s Hospital has discovered a genetic mutation that triggers a disease linked to vampire folklore.
9.8.2017
1:53pm
While the variants in this recessive gene has been linked to higher incidence of skin cancer, researchers have not been able to determine if the variants in...
9.7.2017
12:21pm
New results from the ALEX trial, along with data from the Phase III ALUR trial, will be presented at the European Society for Medical Oncology (ESMO) congress...
9.6.2017
11:41am
Advertisement
Adipose tissue may influence the development of cancer in diverse ways, depending on the type of fat and the location in the body.
9.1.2017
11:59am
The trial will evaluate a formulation of ropinirole delivered via Titan's proprietary ProNeura continuous, long-term drug delivery platform.
8.31.2017
11:19am
The historic action makes Novartis Pharmaceutical’s CAR-T cell treatment the first gene therapy available in the United States, and according to the FDA,...
8.30.2017
12:02pm
More good news for chocolate lovers. Italian researchers have found dark chocolate enriched with extra virgin olive oil was associated with an improved...
8.30.2017
10:25am
A comparison of two different fitness routines shows that both can have an anti-aging effect on the brain in the elderly, but only dancing provides a...
8.29.2017
11:26am
About 25 percent of heart attack patients will experience another cardiovascular event within five years, even if they do not have high cholesterol....
8.28.2017
11:54am
A report released by the Cleveland Clinic last month shared some disappointing news. Its second assessment of the Alzheimer drug pipeline revealed a slow...
8.23.2017
10:47am
Drug Discovery & Development spoke to Joseph Murphy, Ph.D., director of science, R&D at Charles River Laboratories about using NSAIDs as an effective...
8.22.2017
11:49am
Advertisement
The head-to-head comparison pitted Novo Nordisk’s semaglutide against Eli Lilly’s dulaglutide (Trulicity). The SUSTAIN 7 trial results demonstrated that people...
8.17.2017
10:40am
Harvard researchers analyzed more than 2,000 skeletons from cadaveric and archaeological collections across the United States and found that not only has the...
8.15.2017
11:45am
Researchers at Johns Hopkins University found that prehypertension— elevated blood pressure that is not high enough to categorize as high blood pressure, yet...
8.14.2017
10:37am
The study, published in Science Translational Medicine, not only showed immunotherapy to be safe for those diagnosed with type I diabetes, but also that it...
8.10.2017
12:23pm
Researchers at Houston Methodist Research Institute have made an advancement in rejuvenating human cells. It’s no fountain of youth (yet) but for the young...
8.9.2017
10:10am
Preliminary study results show the fruit has a positive impact on those who suffer from IBD.
8.4.2017
10:48am
New research shows that strength training, along with medication, further reduced progression of relapse-remitting multiple sclerosis.
8.3.2017
10:39am
The FDA granted approval for enasidenib (Idhifa) for adult patients with relapsed or refractory AML (R/R AML) with an isocitrate dehydrogenase-2 (IDH2)...
8.2.2017
8:37am
Advertisement
Pericytes, a type of stem cell that surround blood vessels, may be a promising candidate for treatment for heart attack. The research, funded by Heart Research...
7.31.2017
12:00pm
The 9th Annual International AIDS Society (IAS) Conference on HIV Science wrapped up this week. The agenda included 1,700 scientific abstracts and dozens of...
7.28.2017
11:55am
Oracle Health Sciences recently launched Oracle Clinical One, a cloud-based eClinical platform created to help bring drugs to market faster. We spoke with...
7.26.2017
11:48am
Patients in nursing homes that received a high-dose flu vaccine were significantly less likely than residents in homes receiving standard-dose vaccines to go...
7.24.2017
11:38am
The Alzheimer’s Association announced its plans for a $20 million lifestyle intervention trial to prevent cognitive decline in the U.S. at the 2017 Alzheimer...
7.21.2017
11:26am
Healthy eating may preserve cognitive function and reduce the risk of dementia. That’s according to findings from four studies presented at the 2017 Alzheimer’...
7.21.2017
11:05am
Janssen Biotech, Inc., a division of Johnson & Johnson, has announced U.S. FDA approval of guselkumab (Tremfya) for the treatment of moderate to severe...
7.17.2017
11:40am
Data from HAVEN 1 was released at the International Society of Thrombosis and Hemostasis (ISTH) and published in the New England Journal of Medicine. Interim...
7.14.2017
10:39am
The best thing about waking up? It may be the health benefits in your cup. Two large (or should we say, Venti?) studies found coffee consumption associated...
7.12.2017
12:09pm
Researchers at Case Western Reserve University found high doses of vitamin D may reduce swelling, redness, and inflammation after sunburn.
7.7.2017
11:04am
Drug Discovery & Development spoke with Glenmark’s president and chief medical officer, Fred Grossman, DO, FAPA, who presented at the 2017 BIO...
7.6.2017
10:53am
The FDA committed to eliminate the backlog within 90 days and responding to all new requests for designation within 90 days of receipt.
6.30.2017
11:46am
Today is National HIV Testing Day. The campaign from the Centers for Disease Control and Prevention (CDC) raises awareness of testing for early diagnosis of...
6.27.2017
11:49am
Haegarda is a self-administered, plasma-derived concentrate of C1 esterase inhibitor (C1-INH) injected twice weekly subcutaneously.
6.26.2017
11:56am
The new formulation of rituximab can be administered in five to seven minutes via injection versus 90 minutes or longer with intravenous infusion.
6.23.2017
12:05pm
Lion Biotechnologies, Inc.’s LN-144 achieved a 29 percent objective response rate in a study of patients with advanced metastatic melanoma.
6.23.2017
10:28am
Goals of the Institute for Protein Innovation include training the next generation of protein scientists and entrepreneurs, building a large catalog of...
6.22.2017
11:34am
The study, published in Annals of Neurology, was based on a hypothesis that targeting limbic neural pathways would modulate the affective sphere of pain and...
6.21.2017
11:52am